Prokupets Elena's Form 4 filing
C4 Therapeutics, Inc.CCCC · filed Sep 16, 2021
- Accession no.
- 0001209191-21-056482
- Filed
- Sep 16, 2021
- Trade date
- Sep 14-16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $3.98M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prokupets ElenaCIK 0001824823 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | SSaleDisposed | −492 | $50.01F2 | −$24,604.92 | 83,522 | Indirect | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −492 | $50.03F2 | −$24,614.76 | 587,731 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −30,000 | $48.71F5 | −$1,461,300 | 53,522 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −24,193 | $48.97F6 | −$1,184,731.21 | 563,538 | Indirect | |
| Sep 16, 2021 | Common Stock | SSaleDisposed | −346 | $50.01F7 | −$17,303.46 | 53,176 | Indirect | |
| Sep 16, 2021 | Common Stock | SSaleDisposed | −25,807 | $48.62F8 | −$1,254,736.34 | 510,731 | Indirect | |
| Sep 16, 2021 | Common Stock | SSaleDisposed | −346 | $50.01F9 | −$17,303.46 | 510,385 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.145. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 2 transactions in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.25 to $49.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.50 to $49.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.045. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.